These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 27784173)

  • 1. High performance enzyme kinetics of turnover, activation and inhibition for translational drug discovery.
    Zhang R; Wong K
    Expert Opin Drug Discov; 2017 Jan; 12(1):17-37. PubMed ID: 27784173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of receptor allosterism and its implication for drug discovery.
    Zhang R; Kavana M
    Expert Opin Drug Discov; 2015 Jul; 10(7):763-80. PubMed ID: 25927503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Michaelis-Menten from an In Vivo Perspective: Open Versus Closed Systems.
    Gabrielsson J; Peletier LA
    AAPS J; 2018 Sep; 20(6):102. PubMed ID: 30209711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using quantitative systems pharmacology for novel drug discovery.
    Pérez-Nueno VI
    Expert Opin Drug Discov; 2015 Dec; 10(12):1315-31. PubMed ID: 26328768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical cytochrome p450 kinetics: implications for drug discovery.
    Tracy TS
    Drugs R D; 2006; 7(6):349-63. PubMed ID: 17073518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exact and approximate solutions for the decades-old Michaelis-Menten equation: Progress-curve analysis through integrated rate equations.
    Goličnik M
    Biochem Mol Biol Educ; 2011; 39(2):117-25. PubMed ID: 21445903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A guide to the Michaelis-Menten equation: steady state and beyond.
    Srinivasan B
    FEBS J; 2022 Oct; 289(20):6086-6098. PubMed ID: 34270860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Providing data science support for systems pharmacology and its implications to drug discovery.
    Hart T; Xie L
    Expert Opin Drug Discov; 2016; 11(3):241-56. PubMed ID: 26689499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of enzyme turnover on the dynamics of the Michaelis-Menten model.
    Peletier LA; Gabrielsson J
    Math Biosci; 2022 Apr; 346():108795. PubMed ID: 35257739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The virtue of translational PKPD modeling in drug discovery: selecting the right clinical candidate while sparing animal lives.
    Bueters T; Ploeger BA; Visser SA
    Drug Discov Today; 2013 Sep; 18(17-18):853-62. PubMed ID: 23665277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural systems pharmacology: a new frontier in discovering novel drug targets.
    Tan H; Ge X; Xie L
    Curr Drug Targets; 2013 Aug; 14(9):952-8. PubMed ID: 23597016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic models enable the rational use of in vitro drug-target binding kinetics for better drug effects in patients.
    de Witte WE; Wong YC; Nederpelt I; Heitman LH; Danhof M; van der Graaf PH; Gilissen RA; de Lange EC
    Expert Opin Drug Discov; 2016; 11(1):45-63. PubMed ID: 26484747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo potency revisited - Keep the target in sight.
    Gabrielsson J; Peletier LA; Hjorth S
    Pharmacol Ther; 2018 Apr; 184():177-188. PubMed ID: 29024741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme kinetics: the whole picture reveals hidden meanings.
    Pinto MF; Estevinho BN; Crespo R; Rocha FA; Damas AM; Martins PM
    FEBS J; 2015 Jun; 282(12):2309-16. PubMed ID: 25808291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systems Pharmacology in Small Molecular Drug Discovery.
    Zhou W; Wang Y; Lu A; Zhang G
    Int J Mol Sci; 2016 Feb; 17(2):246. PubMed ID: 26901192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond the Michaelis-Menten: Bayesian Inference for Enzyme Kinetic Analysis.
    Hong H; Choi B; Kim JK
    Methods Mol Biol; 2022; 2385():47-64. PubMed ID: 34888715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of drug-target residence time.
    Zhang R; Monsma F
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):488-96. PubMed ID: 19562645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systems pharmacology - Towards the modeling of network interactions.
    Danhof M
    Eur J Pharm Sci; 2016 Oct; 94():4-14. PubMed ID: 27131606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying biological activity in chemical terms: a pharmacology primer to describe drug effect.
    Kenakin T
    ACS Chem Biol; 2009 Apr; 4(4):249-60. PubMed ID: 19193052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the estimation errors of K
    Stroberg W; Schnell S
    Biophys Chem; 2016 Dec; 219():17-27. PubMed ID: 27677118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.